Join ACGT at the ACGT 2020 Cancer Summit as we work together with researchers and patients to eliminate cancer in our lifetime.
Read More-->
of public donations go directly to programs and research
million in grants
top medical institutions funded in the United States and Canada
In his ACGT-funded study, Dr. Sena-Esteves explored how to use a viral strategy to create a zone of resistance in the brain where normal tissue could be modified to prevent tumors from growing, and ultimately, to destroy them. His studies revealed that adeno-associated viral vectors could do the job, but not without long-term toxicity consequences for cancer patients.
Learn More
With support from Alliance for Cancer Gene Therapy (ACGT), a multi-disciplinary team of immunologists, bioengineers and geneticists led by Dr. Stephan is advancing new pre-clinical strategies that combine principles of bioengineering with gene therapy to improve the effectiveness of therapeutic cancer vaccines.
Learn More
With funding from Alliance for Cancer Gene Therapy (ACGT), Dr. Powell is leading a phase I clinical trial, testing a new approach to T-cell therapy he hopes will achieve dramatic results. Unlike traditional chemotherapy and radiation, Dr. Powell uses an immunotherapy approach to achieve dramatic results in women with ovarian cancer.
Learn MoreSince 2001, ACGT has been the only non-profit exclusively funding cancer cell and gene therapy research. From treating the first patients to funding today’s most innovative research — ACGT has been driving forward cell and gene therapy for cancer patients. 100% of all public donations are dedicated to funding research and program. Administrative costs are funded through a separate fund.
GET TO KNOW USCancer cell and gene research breakthroughs are changing our understanding of cancer biology and rapidly advancing new therapies like CAR-T that are changing patients’ lives. We are at the beginning of incredible advances in cancer therapy and we’ll be there at the end – with patients living cancer-free.
DISCOVER THE POTENTIALACGT 2020 Research Awards. This award is for solid tumor research with preference given to glioblastoma and pancreatic cancers. RFA is now closed. Grant Awards will be announced end of April, 2020.
LEARN MOREImmunotherapy for Cancer - A Discussion of New Treatments for Sarcoma and Beyond
VIEW MORE
